Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa

References

• Guide SV, Gonzalez ME, Bağcı IS, et al. Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa. N Engl J Med. 2022;387(24):1–9. doi:10.1056/NEJMoa2206663.
   PubMed Web of Science ®Google Scholar
• Shinkuma S. Dystrophic epidermolysis bullosa: a review. Clin Cosmet Investig Dermatol. 2015;8:275–284. doi:10.2147/CCID.S54681.
   PubMed Web of Science ®Google Scholar
• Bardhan A, Bruckner-Tuderman L, Chapple ILC, et al. Epidermolysis bullosa. Nat Rev Dis Primers. 2020;6(1):78. doi:10.1038/s41572-020-0210-0.
   PubMed Web of Science ®Google Scholar
• Devries DT, Johnson LB, Weiner M, et al. Relative extent of skin involvement in inherited epidermolysis bullosa (EB): composite regional anatomic diagrams based on the findings of the national EB registry, 1986 to 2002. J Am Acad Dermatol. 2004;50(4):572–581. doi:10.1016/j.jaad.2003.09.026.
   PubMed Web of Science ®Google Scholar
• Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry. JAMA Dermatol. 2016;152(11):1231–1238. doi:10.1001/jamadermatol.2016.2473.
   PubMed Web of Science ®Google Scholar
• Fulchand S, Harris N, Li S, et al. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: a global cross-sectional survey. Pediatr Dermatol. 2021;38(5):1198–1201. doi:10.1111/pde.14802.
   PubMed Web of Science ®Google Scholar
• Intong LRA, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol. 2012;30(1):70–77. doi:10.1016/j.clindermatol.2011.03.012.
   PubMed Web of Science ®Google Scholar
• Fine JD, Eady RAJ, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol. 2008;58(6):931–950. doi:10.1016/j.jaad.2008.02.004.
   PubMed Web of Science ®Google Scholar
• Bonamonte D, Filoni A, De Marco A, et al. Squamous cell carcinoma in patients with inherited epidermolysis bullosa: review of current literature. Cells. 2022;11(8):1365. doi:10.3390/cells11081365.
   PubMed Web of Science ®Google Scholar
• Robertson SJ, Orrin E, Lakhan MK, et al. Cutaneous squamous cell carcinoma in epidermolysis bullosa: a 28-year retrospective study. Acta Derm Venereol. 2021;101(8):adv00523. doi:10.2340/00015555-3875.
   PubMedGoogle Scholar
• Siepe P, Roessing C, Safi A. Dystrophic epidermolysis bullosa: surgical treatment of advanced hand deformities. Handchir Mikrochir Plast Chir. 2002;34(5):307–313.
   PubMedGoogle Scholar
• Tang JY, Marinkovich MP, Lucas E, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16(1):175. doi:10.1186/s13023-021-01811-7.
   PubMed Web of Science ®Google Scholar
• Eichstadt S, Tang JY, Solis DC, et al. From clinical phenotype to genotypic modelling: incidence and prevalence of recessive dystrophic epidermolysis bullosa (RDEB). Clin Cosmet Investig Dermatol. 2019;12:933–942. doi:10.2147/CCID.S232547.
   PubMed Web of Science ®Google Scholar
• Feinstein JA, Jambal P, Peoples K, et al. Assessment of the timing of milestone clinical events in patients with epidermolysis bullosa from North america. JAMA Dermatol. 2019;155(2):196–203. doi:10.1001/jamadermatol.2018.4673.
   PubMed Web of Science ®Google Scholar
• Has C, Hess M, Anemüller W, et al. Epidemiology of inherited epidermolysis bullosa in Germany. J Eur Acad Dermatol Venereol. 2023;37(2):402–410. doi:10.1111/jdv.18637.
   PubMed Web of Science ®Google Scholar
• Feinstein JA, Bruckner AL, Chastek B, et al. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2022;17(1):367. doi:10.1186/s13023-022-02509-0.
   PubMed Web of Science ®Google Scholar
• Bruckner AL, Losow M, Wisk J, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2020;15(1):1. doi:10.1186/s13023-019-1279-y.
   PubMed Web of Science ®Google Scholar
• Soro L, Bartus C, Purcell S. Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies. J Clin Aesthet Dermatol. 2015;8(5):41–46.
   PubMedGoogle Scholar
• Flannery D, Doyle C, Hickey S, et al. Direct costs of epidermolysis bullosa by disease severity. Acta Derm Venereol. 2020;100(8):adv00116. doi:10.2340/00015555-3456.
   PubMedGoogle Scholar
• Grocott P, Graham T, Blackwell R, et al. Individualising wound care research: the woundcare for epidermolysis bullosa project. Wounds UK. 2013;9(3):23–32.
   Google Scholar
• Jeon IK, On HR, Kim SC. Quality of life and economic burden in recessive dystrophic epidermolysis bullosa. Ann Dermatol. 2016;28(1):6–14. doi:10.5021/ad.2016.28.1.6.
   PubMed Web of Science ®Google Scholar
• Kirkorian AY, Weitz NA, Tlougan B, et al. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity. Pediatr Dermatol. 2014;31(1):33–37. doi:10.1111/pde.12243.
   PubMed Web of Science ®Google Scholar
• Condorelli AG, Dellambra E, Logli E, et al. Epidermolysis bullosa-associated squamous cell carcinoma: from pathogenesis to therapeutic perspectives. Int J Mol Sci. 2019;20(22):5707. doi:10.3390/ijms20225707.
   PubMed Web of Science ®Google Scholar
• Ahmad RCS, Bruckner AL. A survey of epidermolysis bullosa care in the United States and Canada. Pediatr Dermatol. 2014;31(2):169–175. doi:10.1111/pde.12258.
   PubMed Web of Science ®Google Scholar
• Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5(1):12. doi:10.1186/1750-1172-5-12.
   PubMedGoogle Scholar
• Rashidghamat E, McGrath JA. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis Res. 2017;6(1):6–20. doi:10.5582/irdr.2017.01005.
   PubMed Web of Science ®Google Scholar
• Prodinger C, Reichelt J, Bauer JW, et al. Epidermolysis bullosa: advances in research and treatment. Exp Dermatol. 2019;28(10):1176–1189. doi:10.1111/exd.13979.
   PubMed Web of Science ®Google Scholar
• Gurevich I, Agarwal P, Zhang P, et al. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial. Nat Med. 2022;28(4):780–788. doi:10.1038/s41591-022-01737-y.
   PubMed Web of Science ®Google Scholar
• Bruckner-Tuderman L, Höpfner B, Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol. 1999;18(1):43–54. doi:10.1016/s0945-053x(98)00007-9.
   PubMed Web of Science ®Google Scholar
• VYJUVEK® [beremagene geperpavec-svdt]. Package insert. Krystal Biotech, Inc; 2023. Accessed January 8th, 2024 from https://www.fda.gov/vaccines-blood-biologics/vyjuvek.
   Google Scholar
• Manjunath S, Mahajan R, De D, et al. The severity of malnutrition in children with epidermolysis bullosa correlates with disease severity. Sci Rep. 2021;11(1):16827. doi:10.1038/s41598-021-96354-z.
   PubMed Web of Science ®Google Scholar
• Krämer S, Lucas J, Gamboa F, et al. Clinical practice guidelines: oral health care for children and adults living with epidermolysis bullosa. Spec Care Dentist. 2020;40 Suppl 1(Suppl 1):3–81. doi:10.1111/scd.12511.
   PubMedGoogle Scholar
• Krämer SM, Serrano MC, Zillmann G, et al. Oral health care for patients with epidermolysis bullosa – best clinical practice guidelines. Int J Paediatr Dent. 2012;22 Suppl 1:1–35. doi:10.1111/j.1365-263X.2012.01247.x.
   PubMed Web of Science ®Google Scholar
• Liy-Wong C, Tarango C, Pope E, et al. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. Orphanet J Rare Dis. 2023;18(1):38. doi:10.1186/s13023-022-02448-w.
   PubMed Web of Science ®Google Scholar
• Pope E, Lara-Corrales I, Mellerio J, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol. 2012;67(5):904–917. doi:10.1016/j.jaad.2012.01.016.
   PubMed Web of Science ®Google Scholar
• Mendham JE. Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. Burns. 2004;30(8):851–853. doi:10.1016/j.burns.2004.05.009.
   PubMed Web of Science ®Google Scholar
• Allegaert K, Naulaers G. Gabapentin as part of multimodal analgesia in a newborn with epidermolysis bullosa. Paediatr Anaesth. 2010;20(10):972–973. doi:10.1111/j.1460-9592.2010.03396.x.
   PubMed Web of Science ®Google Scholar
• Boesen ML, Bygum A, Hertz JM, et al. Newborn with severe epidermolysis bullosa: to treat or not to treat? BMJ Case Rep. 2016;2016:bcr2016214727. doi:10.1136/bcr-2016-214727.
   PubMedGoogle Scholar
• Saki N, Vahedi S, Parvizi MM, et al. Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: a pilot, double-blind, split-site, randomized controlled trial. Dermatol Ther. 2022;35(10):e15767.
   PubMed Web of Science ®Google Scholar
• Darbord A, Hickman G, Pironon N, et al. Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity. J Eur Acad Dermatol Venereol. 2021;36Sep 20; (1):133–143. doi:10.1111/jdv.17671.
   PubMed Web of Science ®Google Scholar
• Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin. 2010;28(2):257–264. viii-ix. doi:10.1016/j.det.2010.01.002.
   PubMed Web of Science ®Google Scholar
• Martinez-Moreno A, Ocampo-Candiani J, Alba-Rojas E. Epidermolysis bullosa with congenital absence of skin: review of the literature. Pediatr Dermatol. 2020;37(5):821–826. doi:10.1111/pde.14245.
   PubMed Web of Science ®Google Scholar
• Debra of America. “How to: prepare a bath for epidermolysis bullosa (EB).” Accessed January 8th, 2024 at https://www.debra.org/sites/default/files/howto/How%20To%20PDFs/Nov%202023%20Updated%20PDFs/HowTo-PrepareBath-PDF-11.17.2023.pdf.
   Google Scholar
• Spaulding L. “Basic Care Tips for Epidermolysis Bullosa (EB): A Parent’s Guide.” Standford Medicine. Accessed January 2nd, 2024 from https://med.stanford.edu/content/dam/sm/dermatology/documents/gsdc/eb_clinic/eb-physician-resources/EB%20care%20tips.pdf.
   Google Scholar
• Mellerio JE. Infection and colonization in epidermolysis bullosa. Dermatol Clin. 2010;28(2):267–269, ix. doi:10.1016/j.det.2010.01.004.
   PubMed Web of Science ®Google Scholar
• Stolarczyk A, Perez-Nazario N, Knowlden SA, et al. Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis. Arch Dermatol Res. 2023;315(10):2883–2892. doi:10.1007/s00403-023-02723-1.
   PubMed Web of Science ®Google Scholar
• Croughan WS, Behbehani AM. Comparative study of inactivation of herpes simplex virus types 1 and 2 by commonly used antiseptic agents. J Clin Microbiol. 1988;26(2):213–215. doi:10.1128/jcm.26.2.213-215.1988.
   PubMed Web of Science ®Google Scholar
• Sanekata T, Fukuda T, Miura T, et al. Evaluation of the antiviral activity of chlorine dioxide and sodium hypochlorite against feline calicivirus, human influenza virus, measles virus, canine distemper virus, human herpesvirus, human adenovirus, canine adenovirus and canine parvovirus. Biocontrol Sci. 2010;15(2):45–49. doi:10.4265/bio.15.45.
   PubMed Web of Science ®Google Scholar
• Asch S, Vork DL, Joseph J, et al. Comparison of bleach, acetic acid, and other topical anti-infective treatments in pediatric atopic dermatitis: a retrospective cohort study on antibiotic exposure. Pediatr Dermatol. 2019;36(1):115–120. doi:10.1111/pde.13663.
   PubMed Web of Science ®Google Scholar
• Petersen BW, Arbuckle HA, Berman S. Effectiveness of saltwater baths in the treatment of epidermolysis bullosa. Pediatr Dermatol. 2015;32(1):60–63. doi:10.1111/pde.12409.
   PubMed Web of Science ®Google Scholar
• Mellerio JE, Robertson SJ, Bernardis C, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174(1):56–67. doi:10.1111/bjd.14104.
   PubMed Web of Science ®Google Scholar
• Abboud L, Leclerc-Mercier S, Bodemer C, et al. Hand surgery in recessive dystrophic epidermolysis bullosa: our experience with dermal substitutes. J Plast Reconstr Aesthet Surg. 2022;75(1):314–324. doi:10.1016/j.bjps.2021.05.056.
   PubMed Web of Science ®Google Scholar
• Tuncer S, Sezgin B, Kaya B, et al. An algorithmic approach for the management of hand deformities in dystrophic epidermolysis bullosa. J Plast Surg Hand Surg. 2017;52(2):80–86. doi:10.1080/2000656X.2017.1338183.
   PubMed Web of Science ®Google Scholar
• Box R, Bernardis C, Pleshkov A, et al. Hand surgery and hand therapy clinical practice guideline for epidermolysis bullosa. Orphanet J Rare Dis. 2022;17(1):406. doi:10.1186/s13023-022-02282-0.
   PubMed Web of Science ®Google Scholar
• Saxena A, Lee JB, Humphreys TR. Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa. Dermatol Surg. 2006;32(1):128–134. doi:10.1097/00042728-200601000-00029.
   PubMed Web of Science ®Google Scholar
• Hubbard LD. Long-term outcomes in adults with recessive dystrophic epidermolysis bullosa fed by a gastronomy tube in situ. Int J Dermatol. 2016;55(2):181–186. doi:10.1111/ijd.12876.
   PubMed Web of Science ®Google Scholar
• Salera S, Tadini G, Rossetti D, et al. A nutrition-based approach to epidermolysis bullosa: causes, assessments, requirements and management. Clin Nutr. 2020;39(2):343–352. doi:10.1016/j.clnu.2019.02.023.
   PubMed Web of Science ®Google Scholar
• Vetencourt AT, Sayed-Ahmed I, Gomez J, et al. Ocular gene therapy in a patient with dystrophic epidermolysis bullosa. N Engl J Med. 2024;390(6):530–535. doi:10.1056/NEJMoa2301244.
   PubMed Web of Science ®Google Scholar